[1]
R. DASARAJU, P. BAPUGOUDA, M. BENDE, A. MANGALGIRI, and T. MUPPALA, “AUDIT OF USFDA APPROVALS FOR 2022 FROM THE PERSPECTIVE OF INNOVATION”, Asian J Pharm Clin Res, vol. 16, no. 7, pp. 53–57, Jul. 2023.